AB
Adze Biotechnology Inc
SEC filingBiotechnology · Coral Gables, FL
Amount raised$6.2Msold at filing
Total offering$15M$8.8M still open
Investors in the raise21count reported to the SEC
FiledNov 17, 2025first sale Mar 10, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brendan Patrick KennyDirector
Sidney HoppsExecutive Officer, Director
Gabriel Patrick RavivDirector
G. Patrick Sage, IIDirector
Executive officers, directors and promoters as listed on the Form D.